Virus Archives - Xtalks

Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

Viral Meningitis Week 2026: What to Know About Symptoms, Testing and Research

Healthcare News

Hantavirus Cruise Ship Outbreak Leaves 3 Dead, WHO Investigates Source

Merck’s Enflonsia Gets FDA Nod for Infant RSV Protection to Rival Sanofi and AstraZeneca’s Beyfortus

Life Science Podcast

Innovative Approaches to Antiviral Drug Development

October 16, 2024

Arexvy Shows Strong Efficacy Over Three RSV Seasons in New Phase III Data

October 11, 2024

First Monkeypox Test Approved by WHO for Emergency Use

October 8, 2024

Charting the Course: Strategies for Therapeutic Vaccine Study Success

October 09, 2024

Clesrovimab Shows Promise for RSV in Infants

Moderna’s mRESVIA Wins FDA Approval as First mRNA RSV Vaccine

Leaders in Flu Defense: Insights into the 2024/25 Influenza Vaccine Strategy

World AIDS Vaccine Day 2024: Prospects in HIV Vaccine Research

Arexvy Versus Abrysvo: How Do The RSV Vaccines Compare?

February 20, 2024

GSK’s Arexvy Leads Over Pfizer’s Abrysvo in Year One of RSV Vaccine Market Battle

February 5, 2024

World AIDS Day 2023: New and Promising Treatments for HIV/AIDS

November 30, 2023

Ixchiq Wins FDA Approval as World’s First Chikungunya Vaccine

November 15, 2023

Pfizer’s RSV Vaccine Abrysvo Is a New Step for RSV Prevention

Next Page »